Stay updated with breaking news from Biocon Stock. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Jefferies has downgraded the pharma stock Biocon to 'underperform' from 'hold'. However, Jefferies has maintained its target price of ₹250 for the stock, implying an 11 percent downside from its current market price of ₹281.50.
Biocon Biologics acquired all the global biosimilar businesses of Viatris in November 2022.
Biocon Ltd Share price NSE, BSE today: check share/stock price of BIOCON, get live NSE/BSE stock price of Biocon Ltd with financial reports, peer comparisons, stock performance, about company, shareholding pattern, SWOT analysis on Business Today.
The stock price of Biocon has broken out on the daily chart with higher volumes where it closed at highest level since June 7, 2023
Biocon stock opened with a loss of 9.36% at Rs 181 against the previous close of Rs 199.70 on BSE. The stock touched an intraday low of Rs 347.9, falling 11.73% on BSE.